AA
SRRA

AQR Arbitrage’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

AQR Arbitrage’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-255,367
Closed -$14M – 1594
2022
Q2 		$14M Buy
+255,367
New +$13.4M 0.32% 75

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

AQR Arbitrage's SRRA Position: Q3 2022 in Review

AQR Arbitrage sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 255,367 shares — an estimated $14M sold.

AQR Arbitrage first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $14M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • AQR Arbitrage reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AQR Arbitrage sold 255,367 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $14M.
  • AQR Arbitrage first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • AQR Arbitrage's Sierra Oncology, Inc. Common Stock position peaked at $14M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on AQR Arbitrage's 13F filing for Q3 2022, filed 14 Nov 2022.